232 related articles for article (PubMed ID: 20488798)
1. Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.
Tripathy S; Torres-Gonzalez M; Jump DB
J Lipid Res; 2010 Sep; 51(9):2642-54. PubMed ID: 20488798
[TBL] [Abstract][Full Text] [Related]
2. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.
Tripathy S; Lytle KA; Stevens RD; Bain JR; Newgard CB; Greenberg AS; Huang LS; Jump DB
J Lipid Res; 2014 Jul; 55(7):1448-64. PubMed ID: 24814977
[TBL] [Abstract][Full Text] [Related]
4. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.
Wang Y; Torres-Gonzalez M; Tripathy S; Botolin D; Christian B; Jump DB
J Lipid Res; 2008 Jul; 49(7):1538-52. PubMed ID: 18376007
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid regulation of hepatic lipid metabolism.
Jump DB
Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):115-20. PubMed ID: 21178610
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.
Zeng XY; Wang YP; Cantley J; Iseli TJ; Molero JC; Hegarty BD; Kraegen EW; Ye Y; Ye JM
PLoS One; 2012; 7(7):e42115. PubMed ID: 22860063
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the chicken fatty acid elongases.
Gregory MK; Geier MS; Gibson RA; James MJ
J Nutr; 2013 Jan; 143(1):12-6. PubMed ID: 23173174
[TBL] [Abstract][Full Text] [Related]
8. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance.
Sun H; Jiang T; Wang S; He B; Zhang Y; Piao D; Yu C; Wu N; Han P
Diabetes Res Clin Pract; 2013 Dec; 102(3):183-92. PubMed ID: 24262945
[TBL] [Abstract][Full Text] [Related]
9. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.
Moon YA; Hammer RE; Horton JD
J Lipid Res; 2009 Mar; 50(3):412-423. PubMed ID: 18838740
[TBL] [Abstract][Full Text] [Related]
10. Influence of dietary fatty acids on muscle fatty acid composition and expression levels of Δ6 desaturase-like and Elovl5-like elongase in common carp (Cyprinus carpio var. Jian).
Ren HT; Yu JH; Xu P; Tang YK
Comp Biochem Physiol B Biochem Mol Biol; 2012 Oct; 163(2):184-92. PubMed ID: 22677415
[TBL] [Abstract][Full Text] [Related]
11. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
[TBL] [Abstract][Full Text] [Related]
12. Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycemia: evidence for a combined transcriptional dysregulation of gluconeogenesis and fatty acid synthesis.
Becker W; Kluge R; Kantner T; Linnartz K; Korn M; Tschank G; Plum L; Giesen K; Joost HG
J Mol Endocrinol; 2004 Feb; 32(1):195-208. PubMed ID: 14766002
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
14. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
15. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
Garcia Caraballo SC; Comhair TM; Houten SM; Dejong CH; Lamers WH; Koehler SE
J Nutr Biochem; 2014 Dec; 25(12):1263-74. PubMed ID: 25287814
[TBL] [Abstract][Full Text] [Related]
16. Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia.
Pitaloka DMI; Ko CH; Lin MT; Yeh SL; Yeh CL
Nutr Res; 2019 Aug; 68():45-53. PubMed ID: 31419579
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice.
Kabeer SW; Sharma S; Sriramdasu S; Tikoo K
Biol Res; 2024 May; 57(1):27. PubMed ID: 38745315
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
20. Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.
Alkhalidy H; Moore W; Wang A; Luo J; McMillan RP; Wang Y; Zhen W; Hulver MW; Liu D
J Nutr Biochem; 2018 Aug; 58():90-101. PubMed ID: 29886193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
